234 related articles for article (PubMed ID: 31978322)
1. The Antimalarial Natural Product Salinipostin A Identifies Essential α/β Serine Hydrolases Involved in Lipid Metabolism in P. falciparum Parasites.
Yoo E; Schulze CJ; Stokes BH; Onguka O; Yeo T; Mok S; Gnädig NF; Zhou Y; Kurita K; Foe IT; Terrell SM; Boucher MJ; Cieplak P; Kumpornsin K; Lee MCS; Linington RG; Long JZ; Uhlemann AC; Weerapana E; Fidock DA; Bogyo M
Cell Chem Biol; 2020 Feb; 27(2):143-157.e5. PubMed ID: 31978322
[TBL] [Abstract][Full Text] [Related]
2. A Natural Product Puts Malaria on a Low-Fat Diet.
Lucy D; Zhang L; Tate EW
Cell Chem Biol; 2020 Feb; 27(2):137-139. PubMed ID: 32084335
[TBL] [Abstract][Full Text] [Related]
3. Salinipostins A-K, long-chain bicyclic phosphotriesters as a potent and selective antimalarial chemotype.
Schulze CJ; Navarro G; Ebert D; DeRisi J; Linington RG
J Org Chem; 2015 Feb; 80(3):1312-20. PubMed ID: 25584395
[TBL] [Abstract][Full Text] [Related]
4. A chemical proteomics approach for the search of pharmacological targets of the antimalarial clinical candidate albitiazolium in Plasmodium falciparum using photocrosslinking and click chemistry.
Penarete-Vargas DM; Boisson A; Urbach S; Chantelauze H; Peyrottes S; Fraisse L; Vial HJ
PLoS One; 2014; 9(12):e113918. PubMed ID: 25470252
[TBL] [Abstract][Full Text] [Related]
5. Suppression of Drug Resistance Reveals a Genetic Mechanism of Metabolic Plasticity in Malaria Parasites.
Guggisberg AM; Frasse PM; Jezewski AJ; Kafai NM; Gandhi AY; Erlinger SJ; Odom John AR
mBio; 2018 Nov; 9(6):. PubMed ID: 30425143
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii.
Varberg JM; LaFavers KA; Arrizabalaga G; Sullivan WJ
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158278
[TBL] [Abstract][Full Text] [Related]
8. Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.
Qidwai T; Khan F
Chem Biol Drug Des; 2012 Aug; 80(2):155-72. PubMed ID: 22487082
[TBL] [Abstract][Full Text] [Related]
9. Squalestatin is an inhibitor of carotenoid biosynthesis in Plasmodium falciparum.
Gabriel HB; Silva MF; Kimura EA; Wunderlich G; Katzin AM; Azevedo MF
Antimicrob Agents Chemother; 2015; 59(6):3180-8. PubMed ID: 25779575
[TBL] [Abstract][Full Text] [Related]
10. A proteomic glimpse into the effect of antimalarial drugs on Plasmodium falciparum proteome towards highlighting possible therapeutic targets.
Dousti M; Manzano-Román R; Rashidi S; Barzegar G; Ahmadpour NB; Mohammadi A; Hatam G
Pathog Dis; 2021 Jan; 79(1):. PubMed ID: 33202000
[TBL] [Abstract][Full Text] [Related]
11. Diverse Chemical Compounds Target Plasmodium falciparum Plasma Membrane Lipid Homeostasis.
Bhatnagar S; Nicklas S; Morrisey JM; Goldberg DE; Vaidya AB
ACS Infect Dis; 2019 Apr; 5(4):550-558. PubMed ID: 30638365
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity.
Vanaerschot M; Murithi JM; Pasaje CFA; Ghidelli-Disse S; Dwomoh L; Bird M; Spottiswoode N; Mittal N; Arendse LB; Owen ES; Wicht KJ; Siciliano G; Bösche M; Yeo T; Kumar TRS; Mok S; Carpenter EF; Giddins MJ; Sanz O; Ottilie S; Alano P; Chibale K; Llinás M; Uhlemann AC; Delves M; Tobin AB; Doerig C; Winzeler EA; Lee MCS; Niles JC; Fidock DA
Cell Chem Biol; 2020 Jul; 27(7):806-816.e8. PubMed ID: 32359426
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial type II NADH dehydrogenase of Plasmodium falciparum (PfNDH2) is dispensable in the asexual blood stages.
Ke H; Ganesan SM; Dass S; Morrisey JM; Pou S; Nilsen A; Riscoe MK; Mather MW; Vaidya AB
PLoS One; 2019; 14(4):e0214023. PubMed ID: 30964863
[TBL] [Abstract][Full Text] [Related]
14. Biochemical characterization and chemical inhibition of PfATP4-associated Na
Rosling JEO; Ridgway MC; Summers RL; Kirk K; Lehane AM
J Biol Chem; 2018 Aug; 293(34):13327-13337. PubMed ID: 29986883
[TBL] [Abstract][Full Text] [Related]
15. Repurposing drugs to target the malaria parasite unfolding protein response.
Chen Y; Murillo-Solano C; Kirkpatrick MG; Antoshchenko T; Park HW; Pizarro JC
Sci Rep; 2018 Jul; 8(1):10333. PubMed ID: 29985421
[TBL] [Abstract][Full Text] [Related]
16. A Redox-Active Fluorescent pH Indicator for Detecting Plasmodium falciparum Strains with Reduced Responsiveness to Quinoline Antimalarial Drugs.
Jida M; Sanchez CP; Urgin K; Ehrhardt K; Mounien S; Geyer A; Elhabiri M; Lanzer M; Davioud-Charvet E
ACS Infect Dis; 2017 Feb; 3(2):119-131. PubMed ID: 28183182
[TBL] [Abstract][Full Text] [Related]
17. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
[TBL] [Abstract][Full Text] [Related]
18. Artemisinin activity-based probes identify multiple molecular targets within the asexual stage of the malaria parasites Plasmodium falciparum 3D7.
Ismail HM; Barton V; Phanchana M; Charoensutthivarakul S; Wong MH; Hemingway J; Biagini GA; O'Neill PM; Ward SA
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2080-5. PubMed ID: 26858419
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for Two Distinct Compound Classes.
Magistrado PA; Corey VC; Lukens AK; LaMonte G; Sasaki E; Meister S; Wree M; Winzeler E; Wirth DF
ACS Infect Dis; 2016 Nov; 2(11):816-826. PubMed ID: 27933786
[TBL] [Abstract][Full Text] [Related]
20. Mixed Alkyl/Aryl Phosphonates Identify Metabolic Serine Hydrolases as Antimalarial Targets.
Bennett JM; Narwal SK; Kabeche S; Abegg D; Hackett F; Yeo T; Li VL; Muir RK; Faucher FF; Lovell S; Blackman MJ; Adibekian A; Yeh E; Fidock DA; Bogyo M
bioRxiv; 2024 Jan; ():. PubMed ID: 38260474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
